Business Wire

SEKISUI-HOUSE

30.11.2022 12:57:44 CET | Business Wire | Press release

Share
The University of Tokyo and Sekisui House Launch Joint Research on Biodiversity and Health

The Graduate School of Agricultural and Life Sciences (GSALS) at the University of Tokyo and Sekisui House, Ltd. will launch a joint research project on biodiversity and human health on December 1, 2022. The project will investigate the benefits that biodiversity and urban natural environments have on human health and wellbeing. This will be the world’s first initiative to comprehensively investigate the effects of interacting with the nearby nature of a garden rich in biodiversity on the health of residents and their attitudes and behavior toward nature.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221129006146/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Application of Sekisui House’s Gohon no Ki concept to detached homes (Photo: Business Wire)

The Laboratory of Conservation Ecology1, Department of Ecosystem Studies, GSALS at the University of Tokyo conducts research on the conservation of urban biodiversity and the management of ecosystem services (the benefits to human society provided by ecosystems). The Laboratory has been studying the relationship between nature and human health since 2016, and its research indicates that interactions with nature can lead to improved human health and wellbeing. However, the question of how these health benefits might vary depending on the quality rather than the quantity of nature has not yet been explored.

In 2020, the Laboratory of Conservation Ecology at the University of Tokyo’s GSALS investigated how two means of interacting with nature—the frequency of green space use and viewing greenery from the windows of homes—affect the mental health of urban residents (self-esteem, life satisfaction, happiness, symptoms of depression/anxiety, and loneliness). The results of this research showed that not only people who frequently use green spaces, but also those who live in houses with green view reported better mental health.² This suggests that people can benefit from the psychological effects of nature from within their own homes even if they are not physically present in green spaces.

In the attached chart, the magnitude of positive (right of the dashed line) and negative (left of the dashed line) effects indicates that each factor has a positive or negative relationship with each mental health measures. For example, “green view” is associated with low levels of depression and anxiety symptoms, while “impact of COVID-19 on income” is associated with high levels of such symptoms. Analysis of the results showed that experiencing nature can affect mental health to the same degree as factors such as income that have been traditionally regarded as important to mental health. 

Since 2001, Sekisui House has been pursuing the conservation of biodiversity by creating green networks in urban residential districts under its Gohon no Ki Project, a proposal for creating gardens and communities with native tree species of the region concerned. Joint research conducted with the University of the Ryukyu’s Kubota Laboratory and Think Nature Inc. since 2019 has revealed that this focus on planting native garden trees in line with the Gohon no Ki Project has increased biodiversity in urban areas (Japan’s three major metropolitan areas) where biodiversity has declined significantly.

The new joint research project will combine analytical methods developed by the Laboratory of Conservation Ecology at the University of Tokyo’s GSALS with Sekisui House’s Gohon no Ki Project to conserve biodiversity in what is the first attempt worldwide to scientifically investigate the effects of biodiverse garden greenery on human health and wellbeing. This research will also aim to demonstrate the importance from the perspective of biodiversity of creating gardens rich in biodiversity rather than simply “greenery.”

The Laboratory of Conservation Ecology at the University of Tokyo’s GSALS is conducting research to test five hypotheses regarding the relationship between human health and interactions with nature under the themes of mental health, physical health, cognitive functions, and community health. For the time being, the new joint research project will focus on two hypotheses related to mental health, and one hypothesis related to cognitive functions. This is, however, a long-term joint research project that will later also look at community health and other themes related to health.

Hypotheses

Theme

Hypothesis

Mental health

1

People who interact with nature in the garden have fewer negative emotions (depression, anxiety symptoms, stress, etc.) and more positive emotions (quality of life, happiness, etc.).

2

People who can view nature through their windows have better mental health.

Cognitive functions

3

Interacting with nature in the garden improves cognitive functions.

Community health

4

Interacting with nature in the garden contributes to community health.

Physical health

5

Exercising in natural surroundings offers more health benefits than indoor exercise.

University of Tokyo GSALS Associate Professor Masashi Soga has commented as follows regarding this joint research project.

“People have always turned to nature for relaxation and tranquility, and recent advances in research and technology have made it possible to quantify such intangible health benefits. However, very little is known about the role played by biodiversity in providing these health benefits. If we could shed light on this topic, we may be able to develop the kind of landscape and green space management that supports coexistence with nature because it is desirable from the perspectives of both conserving biodiversity and enhancing human health.

This joint research project is a large-scale investigation of how interacting with nature in our gardens, perhaps the most familiar nature to most of us, affects our health and well-being. Garden biodiversity is an area that has been difficult to study up to now, but Sekisui House’s nationwide planting data will enable us to conduct the world’s first comprehensive investigation into the relationship between garden biodiversity and human health, and the way people appreciate and interact with nature. Up until now, discussions on the health benefits of nature have tended to focus on relatively large expanses of greenery such as green spaces and forests, but with this new study, we hope to shed light on the importance of actually ‘living with nature.’ Our research outcomes will hopefully be useful to promoting the conservation of urban biodiversity.”

The University of Tokyo GSALS and Sekisui House aim to contribute to the conservation of urban biodiversity and creation of a nature-positive society by sharing the findings of the investigation of the way in which interactions with nearby nature in urban environments affects people’s mental health and the way they appreciate and interact with nature.

Notes

  1. Graduate School of Agricultural and Life Sciences, University of Tokyo, Soga Laboratory: https://www.masashi-soga.com/
  2. A room with a green view: the importance of nearby nature for mental health during the COVID-19 pandemic: https://esajournals.onlinelibrary.wiley.com/doi/10.1002/eap.2248
  3. Sekisui House biodiversity conservation initiative: https://www.sekisuihouse.co.jp/gohon_sp/
  4. Sekisui House’s nature-positive methodology: https://www.sekisuihouse.co.jp/gohon_sp/method/

Graduate School of Agricultural and Life Sciences, University of Tokyo

The University of Tokyo’s Graduate School of Agricultural and Life Sciences provides a step-by-step, systematic education in applied sciences within the field of agriculture. Through its educational and research activities, it aims to nurture people with the kind of insight, practical abilities, and leadership qualities required to address the needs of global society through social, cultural, and industrial activities.

Sekisui House’s Gohon no Ki Project

The Gohon no Ki Project was launched by Sekisui House in 2001 as an initiative to conserve biodiversity through the eco-friendly landscaping and greening of the gardens of its customers with their cooperation. Based on the concept of planting five locally native trees, three for birds and two for butterflies, and using traditional Japanese satoyama landscape as a model, the Gohon no Ki Project proposes greening gardens and local communities with native tree species suited to the local climate and benevolent to birds, butterflies, and other local fauna. In fiscal 2021, Sekisui House planted 1.01 million trees, bringing the number of trees planted since the Gohon no Ki Project was launched in 2001 to 18.1 million trees (as of January 2022). Since 2019, the company has been working with the University of the Ryukyu’s Kubota Laboratory and Think Nature Co., Ltd. to quantitatively evaluate the contribution of network-type greening to urban biodiversity. In 2021, it developed the world’s first mechanism for quantitatively evaluating urban biodiversity using big data on tree numbers, species, location data, and ecosystems to determine the effectiveness of biodiversity conservation, publishing it as the “nature-positive methodology.”

Graduate School of Agricultural and Life Sciences, University of Tokyo Soga Laboratory Data

  1. Soga et al. (2017) Gardening is beneficial for health: a meta-analysis. Preventive Medicine Reports, 5, 92-99.
    URL: https://www.sciencedirect.com/science/article/pii/S2211335516301401
    Overview: A meta-analysis (statistical analysis that combines the results of multiple scientific studies and analyzes whether a certain factor is related to a specific issue) that confirmed that interaction with plants through gardening has positive effects on human health
  2. Soga, Gaston (2016) Extinction of experience: the loss of human-nature interactions. Frontiers in Ecology and the Environment, 14, 94-101.
    URL : https://esajournals.onlinelibrary.wiley.com/doi/full/10.1002/fee.1225
    Overview: A study showing that human interaction with nature is declining in many developed countries, and that this “extinction of experience” may have serious negative implications for human health and the protection of ecosystems
  3. Soga et al. (2020) How can we mitigate against increasing biophobia among children during the extinction of experience? Biological Conservation, 242, 108420.
    URL: https://www.sciencedirect.com/science/article/pii/S0006320719309577
    Overview: A study showing that people who interact with nature only infrequently are more likely to show negative reactions (fear, disgust) toward common insects and other invertebrates

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221129006146/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye